Lv1
20 积分 2023-03-02 加入
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
11小时前
待确认
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
3个月前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
4个月前
已完结
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
5个月前
已完结
Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III non-small-cell lung cancer: A proof-of-concept, phase 2 trial
6个月前
已完结
Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial
7个月前
已完结
Chemotherapy-induced Reversion of Mutant RAS to Wild-type RAS in Metastatic Colorectal Cancer
7个月前
已完结
A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
7个月前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
7个月前
已完结
First-line serplulimab in metastatic colorectal cancer: Phase 2 results of a randomized, double-blind, phase 2/3 trial
8个月前
已完结
皖公网安备34019202002308
